Related Experiment Video
Updated: Feb 16, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
BTK blocks the inhibitory effects of MDM2 on p53 activity
Miran Rada1, Mohammad Althubiti1,2, Akang E Ekpenyong-Akiba1
1Department of Molecular and Cell Biology, Mechanisms of Cancer and Aging Laboratory, University of Leicester, Leicester, UK.
Abstract:
p53 is a tumour suppressor that is activated in response to various types of stress. It is regulated by a complex pattern of over 50 different post-translational modifications, including ubiquitination by the E3 ligase MDM2, which leads to its proteasomal degradation. We have previously reported that expression of Bruton's Tyrosine Kinase (BTK) induces phosphorylation of p53 at the N-terminus, including Serine 15, and increases its protein levels and activity. The mechanisms involved in this process are not completely understood. Here, we show that BTK also increases MDM2 and is necessary for MDM2 upregulation after DNA damage, consistent with what we have shown for other p53 target genes. Moreover, we found that BTK binds to MDM2 on its PH domain and induces its phosphorylation. This suggested a negative regulation of MDM2 functions by BTK, supported by the fact BTK expression rescued the inhibitory effects of MDM2 on p53 transcriptional activity. Indeed, we observed that BTK mediated the loss of the ubiquitination activity of MDM2, a process that was dependent on the phosphorylation functions of BTK. Our data together shows that the kinase activity of BTK plays an important role in disrupting the MDM2-p53 negative feedback loop by acting at different levels, including binding to and inactivation of MDM2. This study provides a potential mechanism to explain how BTK modulates p53 functions.
Insights
Bruton's Tyrosine Kinase (BTK) disrupts the MDM2-p53 feedback loop by inactivating MDM2. BTK phosphorylation of MDM2 reduces MDM2's ubiquitination activity, enhancing tumor suppressor p53 function.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Signaling
Background:
- p53 is a crucial tumor suppressor regulated by post-translational modifications, including MDM2-mediated ubiquitination and degradation.
- Bruton's Tyrosine Kinase (BTK) has been shown to increase p53 protein levels and activity via phosphorylation.
Purpose of the Study:
- To elucidate the mechanisms by which BTK influences p53 regulation, specifically its interaction with MDM2.
- To investigate the role of BTK in the MDM2-p53 negative feedback loop.
Main Methods:
- Western blotting to assess protein levels and phosphorylation.
- Co-immunoprecipitation to study protein-protein interactions.
- Functional assays to evaluate p53 transcriptional activity and MDM2 ubiquitination activity.
Main Results:
- BTK expression increases MDM2 levels and is required for MDM2 upregulation after DNA damage.
- BTK binds to MDM2 and induces its phosphorylation, leading to reduced MDM2 ubiquitination activity.
- BTK kinase activity disrupts the MDM2-p53 negative feedback loop, enhancing p53 tumor suppressor functions.
Conclusions:
- BTK's kinase activity is critical for modulating p53 stability and function by directly interfering with MDM2.
- BTK inactivates MDM2 through phosphorylation, thereby disrupting the negative feedback loop that limits p53 activity.
- This study reveals a novel mechanism for BTK in cancer, highlighting its role in p53 pathway regulation.
Related Concept Videos
Excitatory and Inhibitory Effects of Neurotransmitters
Block Diagram Reduction
The first step in this process is the identification and relocation of a branch point. A branch point, where a...
Elements of Block Diagrams
A block diagram typically includes essential elements such as comparators, blocks, and feedback loops. Each of these elements...
Biological Effects of Radiation
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects

